T1	Participants 694 766	From January 2000 to April 2002, 132 patients were enrolled on the study
T2	Participants 768 841	Patient and tumor characteristics were well balanced between the two arms
T3	Participants 843 890	Patients with cerebral metastases were included
T4	Participants 640 671	patients with advanced melanoma
